UNSPSC 41202033: Influenza virus serological reagents

In this classification, Influenza virus serological reagents are devices used in test to identify specific Influenza virus antibodies in serum. US FDA regulates Influenza virus serological reagents under 21 CFR 866.3330 and under FDA product code GNX.

UNSPSC 41202033 Influenza virus serological reagents, a Commodity code, does not align with the state and local procurement activity recently posted under this code. The solicitations sourced against this code reflect purchases of diagnostic testing supplies and laboratory services for sexually transmitted infection screening, drug testing, HIV and syphilis detection, and general medical diagnostics—not influenza serology. State and local governments soliciting under this code are pursuing reagents, test kits, and analyzer supplies for pathogen detection and confirmatory testing across multiple disease categories, typically as single-award or multiple-award contracts with performance specifications tied to analyzer platform compatibility, CLIA certification requirements, and unit-pricing models. Issuing bodies include state health departments (Illinois Department of Public Health), county health and corrections agencies (Collin County Community Supervision and Corrections Department, Collin County Health Care Services, Gwinnett County), and municipal public health programs (City of Austin). Scope varies from consumable kits and reagents to bundled laboratory services including staffing, result reporting, and quality assurance.

Activity concentrates in Texas (Collin County and Gwinnett County solicitations for drug testing supplies and offender specimen collection; City of Austin for HIV test kits) and Illinois (Illinois Department of Public Health emergency procurements for HIV and syphilis reagents). Representative recent opportunities include the Illinois Department of Public Health's emergency procurement (solicitation 26482DPHOFCDIB52340, due May 19, 2026) for Abbott HIV/Syphilis testing reagents totaling $38,079.50; the City of Austin's IFB 9100 AAM1023 (due July 17, 2026) for Abbott Determine HIV test kits at approximately 375 units annually; Collin County Community Supervision and Corrections Department's RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services, approximately 25,031 tests annually at an estimated contract value of $600,000; and Illinois Department of Public Health's change order (solicitation 27482DPHOFCDIB53956, due October 13, 2026) increasing NG/CT testing from 15,000 to 25,000 units annually under an existing Hologic platform contract, with a revised contract cost of $900,000 over five years. The code shows no recent activity aligned to influenza-specific serology testing.